Curaleaf CEO: Cannabis Revaluation Is Coming | Trade to Black
Insights from Curaleaf's Chairman Boris Jordan on the Cannabis Industry
Current State of Investor Interest
- Boris Jordan highlights a limited investor pool in the cannabis sector, which shifts investments based on news and earnings but hasn't expanded significantly.
- He emphasizes that mere uplisting to major exchanges won't drive stock value; active investor participation is crucial for growth.
Compliance and Regulatory Challenges
- Conversations with major investment firms like BlackRock and Fidelity reveal muted interest due to lack of compliance approvals for investing in cannabis stocks.
- Jordan believes rescheduling cannabis will be pivotal for attracting institutional investors, alongside necessary IRS and FinCEN guidance.
Anticipated Changes in Regulations
- While optimistic about upcoming regulatory changes, he acknowledges the government's slow pace in addressing industry needs.
- The timeline suggests potential clarity by mid-September following the July hearings, although legal challenges may arise.
Strategic Moves for Uplisting
- Jordan discusses the importance of patience during uplisting processes to ensure fundamental business valuation rather than just market presence.
- He notes that a strong capital structure is essential, advocating for higher institutional ownership to stabilize share volatility.
Future Growth and Market Dynamics
- The current preference for debt over equity among institutions presents an opportunity; once equity becomes attractive, rapid growth could follow.
- Jordan predicts inevitable consolidation within the industry as larger players seek significant investments, mirroring trends seen in other sectors.
Optimism Amidst Challenges
- Despite previous struggles within the industry, there’s renewed excitement as companies adapt to changing market conditions post-hemp ban.
- He stresses focusing on building solid businesses as a foundation for attracting investment rather than relying solely on market hype.
Conclusion: A Positive Outlook Ahead
- Overall sentiment points towards gradual improvements in regulations and market dynamics leading to healthier growth prospects by 2024.